Baidu
map

儿童流行性感冒中西医结合防治专家共识

2021-10-25 中国中西医结合学会儿科专业委员会呼吸学组 中国中西医结合儿科学

儿童是流行性感冒(简称流感)的高发人群及重症病例的高危人群,在流感流行季节有较高的患病率,严重者可导致死亡。目前针对流感病毒的特效西药有限,而单一的西药治疗也有其一定的局限性。

中文标题:

儿童流行性感冒中西医结合防治专家共识

发布日期:

2021-10-25

简要介绍:

儿童是流行性感冒(简称流感)的高发人群及重症病例的高危人群,在流感流行季节有较高的患病率,严重者可导致死亡。目前针对流感病毒的特效西药有限,而单一的西药治疗也有其一定的局限性。中医认为流感属于时行感冒,因其易于入里化热、传染性强,亦属中医学"瘟疫"范畴。千百年来,中医中药在防治"瘟疫"方面积累了宝贵的经验,但单用中药治疗也有其局限性。因此,如能中西医结合防治,优势互补,将更有其特殊优势,尤其对于轻症时期的早期干预更为重要。本共识通过中西医相关专家对现代医学防治儿童流感的进展、中医药防治儿童流感的文献分析、药物评价问卷及专家应用经验等制定,以期规范中西医药物的联合使用,切实解决儿童流行性感冒尤其是轻症防治的临床问题。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=儿童流行性感冒中西医结合防治专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f5dbb1c002262684, title=儿童流行性感冒中西医结合防治专家共识, enTitle=, guiderFrom=中国中西医结合儿科学, authorId=0, author=, summary=儿童是流行性感冒(简称流感)的高发人群及重症病例的高危人群,在流感流行季节有较高的患病率,严重者可导致死亡。目前针对流感病毒的特效西药有限,而单一的西药治疗也有其一定的局限性。, cover=https://img.medsci.cn/20211114/1636857478374_1608702.jpg, journalId=0, articlesId=null, associationId=2123, associationName=中国中西医结合学会儿科专业委员会呼吸学组, associationIntro=中国中西医结合学会儿科专业委员会呼吸学组, copyright=0, guiderPublishedTime=Mon Oct 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">儿童是流行性感冒(简称流感)的高发人群及重症病例的高危人群,在流感流行季节有较高的患病率,严重者可导致死亡。目前针对流感病毒的特效西药有限,而单一的西药治疗也有其一定的局限性。中医认为流感属于时行感冒,因其易于入里化热、传染性强,亦属中医学"瘟疫"范畴。千百年来,中医中药在防治"瘟疫"方面积累了宝贵的经验,但单用中药治疗也有其局限性。因此,如能中西医结合防治,优势互补,将更有其特殊优势,尤其对于轻症时期的早期干预更为重要。本共识通过中西医相关专家对现代医学防治儿童流感的进展、中医药防治儿童流感的文献分析、药物评价问卷及专家应用经验等制定,以期规范中西医药物的联合使用,切实解决儿童流行性感冒尤其是轻症防治的临床问题。&nbsp;</span></p>, tagList=[TagDto(tagId=117611, tagName=呼吸系感染性疾病), TagDto(tagId=117618, tagName=儿童流行性感冒)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=8491, guiderKeyword=流行性感冒, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13020, appHits=293, showAppHits=0, pcHits=1277, showPcHits=12723, likes=10, shares=35, comments=21, approvalStatus=1, publishedTime=Tue Nov 16 23:57:56 CST 2021, publishedTimeString=2021-10-25, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Sun Nov 14 13:04:58 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Fri Jan 05 13:46:54 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=儿童流行性感冒中西医结合防治专家共识.pdf)])
儿童流行性感冒中西医结合防治专家共识.pdf
下载请点击:
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1191945, encodeId=d3f4119194522, content=实用,有效, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:27:03 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185158, encodeId=6fb81185158c5, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75a86469955, createdName=ms9000000605988060, createdTime=Mon Jan 17 11:56:50 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183916, encodeId=699c11839163b, content=谢谢,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43715590921, createdName=Derick_11, createdTime=Thu Jan 13 16:51:46 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180704, encodeId=d8451180e04cf, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8503019957, createdName=37299215, createdTime=Wed Jan 05 00:22:42 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081977, encodeId=5bbc10819e7fa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02586412310, createdName=ms2000000645820265, createdTime=Mon Dec 20 08:36:59 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2022-02-10 ms3000000637975859

    实用,有效

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1191945, encodeId=d3f4119194522, content=实用,有效, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:27:03 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185158, encodeId=6fb81185158c5, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75a86469955, createdName=ms9000000605988060, createdTime=Mon Jan 17 11:56:50 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183916, encodeId=699c11839163b, content=谢谢,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43715590921, createdName=Derick_11, createdTime=Thu Jan 13 16:51:46 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180704, encodeId=d8451180e04cf, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8503019957, createdName=37299215, createdTime=Wed Jan 05 00:22:42 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081977, encodeId=5bbc10819e7fa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02586412310, createdName=ms2000000645820265, createdTime=Mon Dec 20 08:36:59 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2022-01-17 ms9000000605988060

    谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1191945, encodeId=d3f4119194522, content=实用,有效, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:27:03 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185158, encodeId=6fb81185158c5, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75a86469955, createdName=ms9000000605988060, createdTime=Mon Jan 17 11:56:50 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183916, encodeId=699c11839163b, content=谢谢,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43715590921, createdName=Derick_11, createdTime=Thu Jan 13 16:51:46 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180704, encodeId=d8451180e04cf, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8503019957, createdName=37299215, createdTime=Wed Jan 05 00:22:42 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081977, encodeId=5bbc10819e7fa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02586412310, createdName=ms2000000645820265, createdTime=Mon Dec 20 08:36:59 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2022-01-13 Derick_11

    谢谢,学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1191945, encodeId=d3f4119194522, content=实用,有效, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:27:03 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185158, encodeId=6fb81185158c5, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75a86469955, createdName=ms9000000605988060, createdTime=Mon Jan 17 11:56:50 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183916, encodeId=699c11839163b, content=谢谢,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43715590921, createdName=Derick_11, createdTime=Thu Jan 13 16:51:46 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180704, encodeId=d8451180e04cf, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8503019957, createdName=37299215, createdTime=Wed Jan 05 00:22:42 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081977, encodeId=5bbc10819e7fa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02586412310, createdName=ms2000000645820265, createdTime=Mon Dec 20 08:36:59 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2022-01-05 37299215

    谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1191945, encodeId=d3f4119194522, content=实用,有效, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:27:03 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185158, encodeId=6fb81185158c5, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75a86469955, createdName=ms9000000605988060, createdTime=Mon Jan 17 11:56:50 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183916, encodeId=699c11839163b, content=谢谢,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43715590921, createdName=Derick_11, createdTime=Thu Jan 13 16:51:46 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180704, encodeId=d8451180e04cf, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8503019957, createdName=37299215, createdTime=Wed Jan 05 00:22:42 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081977, encodeId=5bbc10819e7fa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02586412310, createdName=ms2000000645820265, createdTime=Mon Dec 20 08:36:59 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2021-12-20 ms2000000645820265

    学习了

    0

拓展阅读

WHO 2015~2016年北半球流感季节流行性感冒疫苗成分建议

世界卫生组织(WHO,The World Health Organization) · 2015-02-26

流行性感冒抗病毒药物治疗与预防应用中国专家共识

中华医学会呼吸病学分会 · 2016-01-12

流行性感冒诊疗方案(2018年版)

中华人民共和国国家卫生和计划生育委员会(NHFPC,National Health and Family Planning Commission of China) · 2018-01-09

流行性感冒诊疗方案(2018年版修订版)

中华人民共和国国家卫生健康委员会 · 2018-11-19

Baidu
map
Baidu
map
Baidu
map